Why Is AVEANNA HEALTHCARE H (AVAH) Stock Up Today?

Aveanna Healthcare Holdings (AVAH) shares rose 6.91% to $14.00 following the release of third-quarter financial results that exceeded consensus estimates. The primary driver of the move was a beat in non-GAAP earnings per share and a subsequent upward revision to full-year 2026 revenue and EBITDA guidance.

What Happened

The company reported third-quarter revenue of $695.5 million, representing an 11.8% increase over the prior year period. Net income for the quarter was $45.5 million, compared to $14.1 million in the same period last year. Non-GAAP EPS came in at $0.23, beating the consensus estimate of $0.21 by $0.02.

Aveanna Healthcare raised its full-year 2026 revenue guidance to more than $2.695 billion from a previous view of more than $2.68 billion. The company also lifted its adjusted EBITDA guidance to over $374 million from over $365 million. Raymond James reiterated a Strong Buy rating on the stock following the results. The company filed a Form 8-K with the SEC on November 12, 2026, disclosing the results of operations and financial condition.

What The Data Shows

The stock opened at $12.91, a 1.4% gap down from the prior close of $13.09. The session low was $12.26 at 7:25 AM ET, while the session high reached $14.19 at 9:35 AM ET. Volume so far stands at 0.3 million shares, which is 0.1 times the three-month daily average.

Fundamentals show a market cap of $2.9 billion and a P/E ratio of 10.6. Trailing twelve-month revenue growth is 19.5%, with a net margin of 10.6%. The stock has a beta of 2.01 and a 52-week range of $5.93 to $14.71. Over the last 8 sessions, the stock moved 0.2% from $13.12 to $13.09. Recent insider activity includes six sells totaling $558.5 million over the last 90 days, with no buys recorded. The most recent insider sale was filed on August 24, 2026.

What To Watch

Investors will monitor the stock's reaction to the revised 2026 guidance and any further analyst commentary following the earnings release.